[8-K] Senmiao Technology Limited Reports Material Event

Rhea-AI Filing Summary

Viavi Solutions Inc. (VIAV) has filed a Form 144 disclosing that former CEO and current chairman Richard E. Belluzzo intends to sell 8,385 common shares through Morgan Stanley on or after 01 Aug 2025. Based on the form’s stated market value of $81,500, the proposed sale equals roughly 0.0038 % of the 223.2 million shares outstanding, making the transaction immaterial to the public float.

The notice also details Belluzzo’s recent trading history: over the past three months he sold 25,155 shares in seven trades, yielding approximately $234.8 k in gross proceeds. All shares derive from restricted stock granted on 22 Feb 2017; no cash was paid at acquisition.

The filing contains no financial results, guidance, or operational updates. Form 144 merely signals an intention to sell and does not guarantee execution or imply new information about Viavi’s fundamentals.

Insights

Financial Analyst

TL;DR: Small insider sale (0.0038 % float); neutral for valuation.

Belluzzo’s potential $81 k sale is negligible relative to VIAV’s market capitalization and follows modest selling activity earlier this quarter. There is no accompanying business disclosure, so the filing neither strengthens nor weakens the investment thesis. Insider selling can sometimes foreshadow caution, but the size and frequency here appear consistent with routine diversification. I see no material impact on earnings, liquidity, or share supply.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice; governance implications minimal.

The company continues to follow proper disclosure protocols. All sales are aggregated as required, and the representation that no undisclosed adverse information exists aligns with best-practice compliance. The limited share count and transparent broker arrangement suggest standard portfolio management rather than a strategic exit. Governance risk remains unchanged.

false 0001711012 0001711012 2025-07-29 2025-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2025

SENMIAO TECHNOLOGY LIMITED

(Exact name of registrant as specified in its charter)

Nevada		001-38426		35-2600898
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

16F, Shihao Square, Middle Jiannan Blvd. High-Tech Zone, Chengdu Sichuan, People’s Republic of China		610000
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +86 28 61554399

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		AIHS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. 

On July 29, 2025, Senmiao Technology Limited (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice.

Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until January 26, 2026 (the “Expiration Date”), to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the Expiration Date.

If the Company is unable to regain compliance by the Expiration Date, the Company may be eligible for an additional 180 calendar day compliance period to demonstrate compliance with the bid price requirement. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice to Nasdaq of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180-day period, Nasdaq will notify the Company of its determination to delist the Common Stock, at which point the Company would have an opportunity to appeal the delisting determination to a Hearings Panel.

Following the announcement on July 24, 2025 through a press release and a Current Report on Form 8-K, the Company effectuated a 1:10 reverse stock split on July 29, 2025 with trading began on a split-adjusted basis at the market open on that day.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 1, 2025	SENMIAO TECHNOLOGY LIMITED
	By:	/s/ Xi Wen
	Name:	Xi Wen
	Title:	Chief Executive Officer

2

FAQ

How many Viavi (VIAV) shares does Richard E. Belluzzo plan to sell?

The Form 144 lists 8,385 common shares for potential sale.

What is the dollar value of the proposed insider sale?

At the disclosed market price, the sale is valued at approximately $81,500.

What percentage of Viavi’s outstanding shares does the sale represent?

About 0.0038 % of the company’s 223,236,654 shares outstanding.

Has the insider sold Viavi stock recently?

Yes. Over the past three months Belluzzo sold 25,155 shares for roughly $234.8 k in gross proceeds.

Does the Form 144 filing indicate any change in Viavi’s business outlook?

No. A Form 144 only discloses an intent to sell shares and provides no operational or financial guidance.